about
Climate change and risk of leishmaniasis in north america: predictions from ecological niche models of vector and reservoir speciesRapid tests for the diagnosis of visceral leishmaniasis in patients with suspected diseaseRapid diagnostic tests for visceral leishmaniasisIL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovaniSerological tests for visceral leishmaniasisInhibition of Plasmodium falciparum choline kinase by hexadecyltrimethylammonium bromide: a possible antimalarial mechanismMolecular diagnosis of leishmaniasis: current status and future applicationsNutritional supplements for patients being treated for active visceral leishmaniasisDecentralized control of human visceral leishmaniasis in endemic urban areas of Brazil: a literature reviewLeishmania carbon metabolism in the macrophage phagolysosome- feast or famine?Leishmaniasis in Uganda: historical account and a review of the literatureImmunoregulation in human American leishmaniasis: balancing pathology and protectionSystematic review of biomarkers to monitor therapeutic response in leishmaniasisComparative analysis of the omics technologies used to study antimonial, amphotericin B, and pentamidine resistance in leishmaniaInnate immunity against Leishmania infectionsRecent developments in drug discovery for leishmaniasis and human African trypanosomiasisDeterminants for the development of visceral leishmaniasis diseaseA Luciferase-Expressing Leishmania braziliensis Line That Leads to Sustained Skin Lesions in BALB/c Mice and Allows Monitoring of Miltefosine Treatment OutcomeAn image-based high-content screening assay for compounds targeting intracellular Leishmania donovani amastigotes in human macrophagesTargeting Leishmania major Antigens to Dendritic Cells In Vivo Induces Protective ImmunityAbortive T follicular helper development is associated with a defective humoral response in Leishmania infantum-infected macaquesStructural Basis of Molecular Recognition of the Leishmania Small Hydrophilic Endoplasmic Reticulum-associated Protein (SHERP) at Membrane SurfacesSubstrate Preferences and Catalytic Parameters Determined by Structural Characteristics of Sterol 14α-Demethylase (CYP51) from Leishmania infantumRegulation of immunity during visceral Leishmania infectionNew Approaches to Overcome Transport Related Drug Resistance in Trypanosomatid ParasitesCrosstalk between purinergic receptors and lipid mediators in leishmaniasisPlasticity of the Leishmania genome leading to gene copy number variations and drug resistanceAdvances in Development of New Treatment for LeishmaniasisLeishmaniasis revisited: Current aspects on epidemiology, diagnosis and treatmentThe Utility of Blood and Bone Marrow Films and Trephine Biopsy Sections in the Diagnosis of Parasitic InfectionsOngoing epidemic of cutaneous leishmaniasis among Syrian refugees, LebanonAntiparasitic therapyNeglected tropical diseasesMiltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasisUnresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites.Thrichomys laurentius (Rodentia; Echimyidae) as a putative reservoir of Leishmania infantum and L. braziliensis: patterns of experimental infectionLeishmania-specific surface antigens show sub-genus sequence variation and immune recognitionFirst-line therapy for human cutaneous leishmaniasis in Peru using the TLR7 agonist imiquimod in combination with pentavalent antimonyGene expression profiling and molecular characterization of antimony resistance in Leishmania amazonensisIntracellular targeting specificity of novel phthalocyanines assessed in a host-parasite model for developing potential photodynamic medicine
P2860
Q21562268-76A51A26-08C5-4312-B199-FFC4BB407C14Q24193697-FAFDA2DE-B266-4F10-AF71-79C73337D7C1Q24236732-F46D8446-E33D-49BD-BDB4-12AD57DEB9F0Q24658015-918BC39D-DF2E-4861-B81B-C8D113AA2848Q24672136-AF858BD1-F35F-4FF8-8686-711D67E20446Q24675578-FD3F68A8-D343-4B39-B4FF-6AE28285D2CDQ24678198-C79CFE20-29E2-482E-AF05-B31C83654216Q26471592-BD1E4966-88AE-4D73-BCDB-C11E12FB953FQ26739026-99256CA1-5EF9-48CC-9F6A-9E39DE43F66FQ26776497-120DED2B-8249-4AD7-BBD0-4B57AC229C13Q26830527-E07CFA83-D51B-4D42-9B26-E956ECA1AAAAQ26850280-D7E4E064-5E1F-442E-A787-3D1713F3248AQ26866450-3B842C71-F809-4D55-882E-4BFFCA3372EEQ27009505-3C62667F-FEF7-4795-B590-6099CF16F0D2Q27010187-6E9C968B-EB53-48B9-A955-7C441DDD2D78Q27011766-DE161839-FC9D-43FF-8C0B-BCFC1D662A3EQ27027871-EEBE1DA5-57F4-4389-936E-C02B2D198ECEQ27303693-70B4D1E0-F826-451A-A07E-5B114CFC20EEQ27305418-26CDF2E2-C492-409A-906A-5A95101B4533Q27312070-E914C8B1-4CFB-481F-8CA8-5D4BDE43098AQ27326637-D4A9B180-2797-4154-8BE1-9CD0902CBCEDQ27666058-816EFD2F-4C6D-46C1-AFFE-0C07A686561AQ27668116-65A1D373-0198-469A-A255-29E361A013D4Q28066034-437DC5ED-C19E-40D2-B1E9-C2B14DE4F6A9Q28068159-5BF1B168-EFB1-4CE8-9E20-407835A95869Q28072094-57013FAD-A089-464C-ACBC-1E2C5B3C799BQ28074697-8C2A6E1B-3E72-4FB3-92D5-33852C9C5146Q28082097-A5FB3B17-22D6-44D0-AAFC-0A4326289D4FQ28082283-7974C1A3-17C0-44B1-BEAC-B288E6251777Q28082848-A8F438C7-A422-42D5-A9CE-86151D4E699BQ28114457-C6289161-EB6D-4C87-9E4E-B42677612978Q28239164-C67E5C28-48EA-4138-9A85-EA9666104F2BQ28267545-54A85A9F-EB42-434A-B776-0531DE876133Q28271849-BEB417D0-F3CE-4A70-8E32-83C3358EA6D7Q28468760-9F122B5E-B55C-4F0A-9BD9-FC5DE5148572Q28472737-FFD821D0-DE4C-4995-AF9E-810A0F8FD436Q28475610-B1880CC1-6A54-4B9F-9541-D84C0B1BABAFQ28475794-C7C952B4-B401-45C6-8201-D96A775652EDQ28478242-DC625725-B5CC-4EC5-9042-AD0A06CBBFE2Q28478461-AE50AFD6-F374-4C8B-B1BB-A57770ED4FEE
P2860
description
article publié dans la revue scientifique The Lancet
@fr
artikull shkencor
@sq
artículu científicu
@ast
scientific article published in The Lancet
@en
wetenschappelijk artikel
@nl
գիտական հոդված
@hy
գիտական յօդուած
@hyw
ശാസ്ത്രപ്രബന്ധം
@ml
name
Advances in leishmaniasis
@ast
Advances in leishmaniasis
@en
type
label
Advances in leishmaniasis
@ast
Advances in leishmaniasis
@en
prefLabel
Advances in leishmaniasis
@ast
Advances in leishmaniasis
@en
P2093
P3181
P1433
P1476
Advances in leishmaniasis
@en
P2093
P304
P3181
P356
10.1016/S0140-6736(05)67629-5